DIFFUSE SCLEROSING PNEUMOCYTOMA (SCLEROSING HAEMANGIOMA)
https://doi.org/10.21292/2075-1230-2017-95-4-58-63
Abstract
Sclerosing pneumocytoma is a rare tumor. Most frequently it occurs in women at the age from 30 to 50 years old. Prevalently sclerosing pneumocytoma is a tumor with a single localization at the periphery of the lung. However sometimes diffuse lesions of both lungs can develop, when indurated foci of the tumor are located in the lung tissue. The article presents the clinical case of diffuse sclerosing pneumocytoma in 57-year-old female patient. Marginal excision has been performed for diagnostics of the disease. The set of immunohistochemical stains with monoclonal antibodies was used for accurate identification.
About the Authors
A. A. Sadovnikov
Kostroma Regional Clinical TB Dispensary
Russian Federation
Russian Federation
Candidate of Medical Sciences, Head of Pulmonary Surgery Department,
150b, Lenina St., Kostoma, 156007
K. I. Panchenko
Yaroslavl State Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of Pathological Anatomy Department
5, Revolyutsionnaya St., Yaroslavl, 150000
A. S. Nadezhin
Clinical Oncological Hospital
Russian Federation
Russian Federation
Candidate of Medical Sciences, Associate Professor, Head of Autopsy Department,
67, Oktaybrya Ave., Yaroslavl, 150054
E. N. Kraynova
Clinical Oncological Hospital
Russian Federation
Russian Federation
Pathologist,
67, Oktaybrya Ave., Yaroslavl, 150054
References
1. Paltsev M.А., Аnichkov N.M., Lisochkov N.M., Dvorakovskaya I.V. Opukholi trakhei, bronkhov, parenkhimy legkikh i plevry. Аtlas patologii opukholey cheloveka. [Tumors of trachea, bronchi, pulmonary parenchyma and pleura. Atlas of human tumors]. Moscow, Meditsina Publ., 2005, pp. 382-397.
2. Petrov S.V. Immunogistokhimicheskaya diagnostika opukholey legkikh, mezoteliomy Rukovodstvo po immunogistokhimicheskoy diagnostike opukholey cheloveka. [Immunohistochemical diagnostics of pulmonary tumors, meaothelioma. Guideline on immunohistochemical diagnostics of human tumors]. 4th ed., suppl. and amend., ed. by S.V. Petrov, N.T. Raykhlin. Kazan, 2012, pp. 386-395.
3. Beasley M.B., Travis W.D. Sclerosing pneumocytoma. WHO classification of tumors of the lung, pleura, thymus and heart. Eds. William D. Travis, Elisabeth Brambilla, Allen P. Burke, Alexander Marx, Andrew G. Nicholson-Lyon: IARC. 2015, pp. 110-111.
4. Chan K.W., Gibbs A.R., Lo W.S. et al. Benign sclerosing pneumocytoma of lung (sclerosing haemangioma). Thorax, 1982, vol. 37, pp. 404-412.
5. Devousassoux-Shisheboran M., Hayashi T., Unnoila R.I. et al. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies TTF-1 expressed in bout round and surface cells, suggesting an origin from primitive respiratory epithelium. Am. J. Surg., Pathol., 2000, vol. 24, no. 7, pp. 906-916.
6. Hill G.S., Eggleston J.C. Electron microscopic study of so-called «pulmonary sclerosing hemangioma». Report of a case suggesting epithelial origin. Cancer, 1972, vol. 3, no. 4, pp. 1092-1106.
7. Iyoda A., Hiroshima K., Shiba M. et al. Clinicopathological analysis of pulmonary sclerosing hemangioma. Ann. Thorac. Surg., 2004, vol. 78, pp. 1928-1931.
8. Jungraithmayr W., Eggeling S., Ludwig C. et al. Sclerosing hemangioma of the lung: a benign tumour with potential for malignancy? Ann. Thorac. Cardiovasc. Surg., 2006, vol. 12, no. 5, pp. 352-354.
9. Kennedy A. «Sclerosing haemangioma» of the lung: an alternative view of its development. J. Clin. Pathol., 1973, vol. 26, pp. 792-799.
Review
For citations:
Sadovnikov A.A., Panchenko K.I., Nadezhin A.S., Kraynova E.N. DIFFUSE SCLEROSING PNEUMOCYTOMA (SCLEROSING HAEMANGIOMA). Tuberculosis and Lung Diseases. 2017;95(4):58-63. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-4-58-63
Views:
2050
Email this article 